Animal health pros will enjoy learning about the possibilities synthetic lolamicin might provide. In a new study, researchers identified a compound that kills pathogenic bacteria while sparing friendly gut microbes.
The last time a gram-negative selective antibiotic was introduced for human use was in the 1960s. Bringing lolamicin to market will take several years, but showing that you can get a gram-negative selective compound that doesn’t disturb the gut microbiome may spur more research, says Paul J. Hergenrother, PhD.
Source: The Scientist, November 19, 2024. Link.
Lolamicin, a synthetic antibiotic, attacks harmful bacteria while sparing friendly microbes.”